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Abstract 
Objective 
Our study aims to evaluate the role of pathology 
evaluation of fallopian tubesduring hysterectomy 
for benign indications for the purpose ofearly 
detection of serous tubal intraepithelial 
carcinoma (STIC) in women at high and low risk 
for ovarian cancer. 
Material and methods 
This cross-sectional study was conducted at 
Minia Maternity University Hospital, Egypt, 
between June 2015 and December 2017. Our 
study included all women undergoing 
hysterectomy for benign conditions in the genital 
tract. Appropriate histories were taken, as well 
as physical exams, and laboratory and 
ultrasound evaluations were done prior to 
scheduling surgery. Abdominal hysterectomies 
including opportunistic salpingectomies were 
performed and the whole specimens including 
the tubal fimbria were sent to the pathology lab 
for histo-pathological examination. 
 
Results 
A total of 526 patients met inclusion criteria for 
this study. The mean age of the study 
participants was 49.75±8.95 years, the mean 
parity was 3.91±1.62 and the mean BMI was 
24.21±2.38 Kg/m2. The most common surgical 
indications for hysterectomy were 
postmenopausal bleeding (34.6%), a clinically 
benign adnexal/pelvic mass (31.7%), and 
menorrhagia (24.7%). The fallopian tubes were 
found to have either no pathology or benign 
conditions in 500 out of the 526 patients. Among 
these patients, 56% had no pathologic 
abnormality. The most common benign 
conditions were paratubal cysts (25%), 
endometriosis (9%), torsion (2%) and 
hydrosalpinx (1%). STIC was identified in the 
fallopian tubes of 8 out of 526 patients. 
Conclusions 
Microscopic examination of the entire fimbriae 
from all patients regardless of the clinical context 
represents a novel method of early detection of 
sporadic tubal carcinoma, a putative precursor 
to advanced-stage pelvic cancer. 
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Introduction 
In 2016, an estimated 229,875 women 
were living with ovarian cancer in the 
United States, and the number of 
related deaths was 7.0 per 100,000 
women per year.1 Ovarian cancer was 
the seventh most common cancer 
diagnosed among women in the world, 
and fifth most common cancer diagnosis 
among women in more developed 
regions. The world rate was 6.3 per 
100,000, and is higher in developed 
countries and compared to others.2 
Recent data suggest that intraepithelial 
carcinoma of the fallopian tube [serous 
tubal intraepithelial carcinoma (STIC)] is 
the precursor of high-grade extra-uterine 
serous carcinoma.3 Pelvic serous 
carcinoma is currently the most lethal 
gynecologic cancer in the United States. 
The need for early detection is evident 
as most women present at an advanced 
stage and survival is poor.4 
Progress has been made in developing 
algorithms for identifying and managing 
patients at high risk for hereditary breast 
and ovarian cancer (HBOC) syndrome 
due to BRCA1 or BRCA2 germline 
mutation5, however, HBOC accounts for 
only a minority (10% to 15%) of cases of 
pelvic serous carcinoma.6 
The vast majority is sporadic, and 
effective screening tools for sporadic 
ovarian cancer remain elusive.7 A novel 
approach to early diagnosis is needed. 
The new paradigm for the pathogenesis 
of pelvic serous carcinoma may provide 
an opportunity for early detection.8 Since 
it is now recognized that the earliest 
form of pelvic carcinoma in 
asymptomatic women with a BRCA 
mutation typically presents as a 
noninvasive high-grade STIC, 
examination of the fimbriae can be 
viewed as an early detection tool in 
patients at risk for HBOC who undergo 
risk-reducing salpingo-oophorectomy 
(RRS).9 The diagnosis requires 
complete and systematic pathologic 
evaluation of the fallopian tubes using a 
special protocol for specimen dissection 
since most STICs in this setting are 
occult.10 
The hypothesis of our study is that early 
cancer detection can also be 
accomplished in women at low risk for 
HBOC using similar systematic 
evaluation of fallopian tubes incidentally 
removed during surgery for benign 
indications. Some experts now advocate 
RRS in low-risk women undergoing 
tubal sterilization, hysterectomy, or other 
pelvic surgery for benign indications, so-
called opportunistic salpingectomy.11 
Systematic pathologic evaluation of 
these low risk fallopian tubes may 
translate to significant benefits at a 
population level. Currently, more than 
500,000 benign hysterectomies and 
600,000 tubal ligations are performed 
annually in the United States.12 If these 
procedures were to include bilateral 
RRS, the fimbriae could serve as a 
target for early detection of pelvic 
cancer. 
Therefore, our study aims to evaluate 
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the role of the evaluation of fallopian 
tubes removed during hysterectomy for 
benign indications in early detection of 
STIC in women at high and low risk for 
ovarian cancer 
Materials and methods  
This was a cross-sectional study 
conducted at Minia Maternity University 
Hospital, Egypt between June 2015 and 
December 2017. The Institutional 
Ethical Review Board approved the 
study protocol. Our study included all 
women undergoing hysterectomies for 
benign conditions in the genital tract. 
We excluded women with intraoperative 
findings of any malignancy and those 
with tubal specimens that did not 
contain fimbriae. 
We obtained a written informed consent 
from all women before participationand 
after discussing the nature of the study. 
Patients were recruited from the 
outpatient gynecology clinic. First, the 
participating women were enrolled in the 
screening phase of the study. This 
phase included taking histories, clinical 
examinations, ultrasound evaluations 
and full laboratory investigations. After 
clinical evaluation and consent, 
abdominal hysterectomies, including 
opportunistic salpingectomy, were 
performed and whole specimens 
including the tubal fimbria were sent to 
the pathology lab for histo-pathological 
examination. 
Our protocol is similar to those 
described by others, including the so-
called SEE-FIM protocol.10 In brief; 
tubes were fixed in formalin before 
slicing at 3-mm intervals. The fimbriae 
were sliced parallel to the length of the 
plicae, and the non-fimbriated portion of 
the tube was sliced in cross-sections. All 
tissue slices were submitted for 
microscopic examination with a single 
hematoxylin and eosin (H&E)-stained 
slide prepared from each tissue block.  
Our protocol also included 
standardization of diagnostic criteria. 
Malignancy of the fallopian tube mucosa 
was classified as STIC or invasive tubal 
carcinoma. A diagnosis of STIC required 
the presence of unequivocal 
morphologic and immune-histochemical 
criteria. 
Criteria for STIC include:  
• cellular crowding 
• stratification 
• loss of polarity  
• nuclear enlargement 
• hyperchromasia 
• atypical nuclear contours 
• mitoses 
• loss of cilia 
Invasive carcinoma is diagnosed when: 
• Tumor cells form a confluent solid 
or papillary mass or 
• Present below the basement 
membrane, growing into the 
submucosal connective tissue. 
Results: 
Among the population that had been 
admitted to our center during the period 
Proceedings in Obstetrics and Gynecology, 2019;9(1):2 
 
Opportunistic salpingectomy and ovarian cancer 4 
 
of the study, a total of 526 patients met 
inclusion criteria for this study (516 
patients were low risk and 10 patients 
were high risk for ovarian cancer). The 
mean age of the study participants was 
49.75±8.95 years, the mean parity was 
3.91±1.62 and the mean BMI was 
24.21±2.38 Kg/m2. The most common 
surgical indications for hysterectomy 
were postmenopausal bleeding (34.6%), 
a clinically benign adnexal/pelvic mass 
(31.7%), and menorrhagia (24.7%). 
Table1. Main pathologic diagnoses in 
uterus or ovary 
Diagnosis Number of 
patients 
In uterus  
Leiomyoma 171 
Adenomyosis 125 
Endometrial hyperplasia with atypia 16 
Endometrial hyperplasia without 
atypia 
121 
Atrophic endometritis 40 
No major pathologic abnormality 75 
In ovary  
Benign serous cyst 147 
No major pathologic abnormality 208 
Endometriosis 47 
Benign mucinous cystadenoma 42 
Mature teratoma 10 
Functional cysts 40 
Fibroma 10 
Ovarian abscess 5 
Torsion 10 
Occult high-grade serous carcinoma 2 
Granulosa cell tumor 3 
Brenner tumor 1 
Borderline mucinous ovarian tumor 1 
 
The most common surgical procedures 
performed for patients were bilateral 
salpingo-oophorectomy with 
hysterectomy (31.7%), bilateral 
salpingectomy with unilateral 
oophorectomy and hysterectomy 
(19.5%), and bilateral salpingectomy 
with hysterectomy (15%). 
The main pathologic findings in 
hysterectomy specimens were 
summarized in (Table 1). The ovarian 
pathologic findings were also mentioned 
in Table 1. All cases were benign except 
in three patients. The first presented 
with a clinically suspected adnexal mass 
and was found to have ovarian high-
grade serous carcinoma. The second 
patient presented with a clinically benign 
ovarian cyst was found to have a 
borderline mucinous tumor. The third 
patient, who had a family history of 
breast carcinoma was found to have 
ovarian high-grade serous carcinoma 
and STIC of the ipsilateral fallopian 
tube. 
Table 2. Fallopian tube 
histopathology 
Diagnosis Number of 
patients 
STIC 8 
Atypical mucosal proliferation 15 
Invasive carcinoma 3 
No pathologic abnormality 298 
Tubal endometriosis 47 
Paratubal cysts 136 
Tubo-ovarian abscess 4 
Hydrosalpinx/chronic salpingitis 5 
Torsion 10 
 
The fallopian tubes were found to have 
either no pathology or benign conditions 
in 500 out of the 526 patients (Table 2). 
Among these patients, 56% had no 
pathologic abnormality. The most 
common benign conditions were 
paratubal cysts (25%), endometriosis 
(9%), torsion (2%) and hydrosalpinx 
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(1%). STIC was identified in the 
fallopian tubes of 8 out of 526 patients 
(one in the high risk group represented 
10% of cases and seven in the low risk 
group represented 1.3% of cases). Five 
patients were suspected to have benign 
ovarian cysts, and one patient 
presented with ovarian high-grade 
serous carcinoma. The ovaries of the 
last two patients showed no pathological 
abnormalities (Figure 1). 
The fallopian tubes were grossly normal 
in six patients and contained cysts in the 
other two patients. STIC was confined to 
the fimbriae in five patients, involved 
both the fimbriae and non-fimbriated 
tube in two patients, and involved only 
the non-fimbriated tube in one patient. 
STIC was multifocal in all patients 
except three. The linear span of the 
mucosa involved by STIC ranged from 1 
to 5mm. Seven STICs had a flat growth 
pattern, and one grew in an exophytic, 
tufted, micropapillary pattern (Table 3). 
The ovary of the eighth patient with 
STIC contained occult high-grade 
serous carcinoma. This 47-year-old 
patient had a family history of breast 
cancer (high risk) and a long-standing 
history of pelvic pain from a fibroid 
uterus and endometriosis. 
Fifteen of 526 patients had an abnormal 
mucosal proliferation of the fallopian 
tube but failed to meet full criteria for a 
diagnosis of STIC. There were 
proliferations with mild atypia of 
unknown clinical significance of the sort 
that Vang and colleagues designate as 
“normal/reactive in their classification 
system.13 
The most common surgical indication 
was an adnexal cyst. Except in the case 
of four patients with marked adhesions, 
both tubes were removed.The gross 
appearance of the tubes was normal in 
11 patients; while cysts and surface 
adhesions were grossly visible in the 
tubes of 4 patients. The ovarian 
pathology was benign in all patients. 
These mucosal proliferations involved 
unilateral fimbriae in nine patients, 
bilateral fimbriae in fivepatients, and a 
non-fimbriated tube in one patient. The 
linear span of these proliferations was 
<1mm in all cases. None of these 15 
patients underwent surgical staging, 
received adjuvant therapy, or were 
referred for genetic risk assessment. 
Three of 526 patients had invasive 
carcinoma of the fallopian tube (all of 
them were from the low risk group) 
(Table 4). The tumor was present below 
the basement membrane, growing into 
the submucosal connective tissue 
(Figure 2). Postmenopausal bleeding 
was the most common surgical 
indication. Both tubes were removed in 
all three patients. The ovarian pathology 
was benign in all except one patient, 
who showed occult high-grade serous 
carcinoma. 
 
Proceedings in Obstetrics and Gynecology, 2019;9(1):2 
Opportunistic salpingectomy and ovarian cancer  6 
  
(a)                                                                                     (b) 
 
 




Figure 1.STIC was confined to the non-fimbriated portion of the tube in case (a, b) 
and confined to the fimbriae in case(c, d)
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TAH, total abdominal hysterectomy; BSO, bilateral salpingo-oophorectomy; USO, unilateral salpingo-oophorectomy 
Discussion 
The standard of care for pathologic evaluation of grossly 
normal fallopian tubes removed for benign indications in 
women who are not at high risk for HBOC has been a 
single representative tissue section per tube.14,15 Until 
recently; the fimbriae have been largely ignored in low-
risk patients from a diagnostic perspective. It is now 
established that it is the fimbriated end of the tube that is 
most likely to harbor an occult cancer in high-risk 
patients.10, 16, 17 
Some authors are suggesting that the standard of care 
should be redefined such that the fimbriae are evaluated 
routinely in low as well as in high risk patients to detect 
occult tubal cancer.18 Pathologists outside of academic 
practices may have also begun to extrapolate sampling 
protocols from high-risk patients to low-risk patients and 
may be directing attention to the fimbriae. However, the 
benefits, limitations, costs, and clinical management 
implications have not been fully studied in a prospective 
manner.
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Figure 2. Invasive tubal carcinoma 
Our study demonstrates that the 
presence of tubal carcinoma would have 
gone undetected in the specimens of 7 
of 516 low-risk women and 1 of 10 high 
risk women had the current standard of 
care for tissue sampling been used. 
Thus, systematic examination of the 
fallopian tube fimbriae in low and high 
risk women will indeed identify cases of 
early-stage tubal cancer that would 
otherwise have not been recognized. 
Our findings cannot be directly 
translated to estimate the incidence of 
STIC in the general population of 
women at low or high risk for high-grade 
pelvic serous carcinoma because of the 
study design limitations. These 
limitations include the small sample 
size, the exclusion of women with any 
form of malignancy in the female genital 
tract and the restriction of the high-risk 
population to those who have elevated 
HBOC risk. The clinical significance of 
STIC in low-risk patients is unknown. 
The follow-up time in our study is too 
limited to draw any conclusions about 
behavior; however, at least three of our 
patients had concurrent invasive tubal 
carcinoma, and one of them had occult 
ovarian cancer. Thus, the possibility of 
concurrent advanced-stage occult 
cancer should be considered in low as 
well as high risk patients found to have 
STIC. If STIC is neglected in low-risk 
patients, it can subsequently progress to 
advanced-stage pelvic cancer.  
Since the development of STIC is also 
likely related to patient age, it may be 
reasonable to propose enhanced tissue 
sampling strategies as a function of 
Proceedings in Obstetrics and Gynecology, 2019;9(1):2 
 
Opportunistic salpingectomy and ovarian cancer 9 
 
patient age.  
In our study, all the patients with STIC 
were over the age of 40, which may 
represent a minimum age for defining 
concern for STIC in low and high-risk 
women. In our study most of the STIC 
cases presented with a grossly cystic 
ovary (either an epithelial cystic 
neoplasm or cystic teratoma), so 
whether ovarian findings should also 
guide concern for occult STIC should be 
considered.   
The main source of STIC is the fimbria 
(five of eight cases STIC and 14 of 15 
cases atypical mucosal proliferation), so 
we propose that it is reasonable to 
examine the entire fimbriae but only a 
representative section of the non-
fimbriated tube. It is conceivable that 
this protocol may miss a rare case in 
which STIC is restricted to the 
unsampled non-fimbriated tube without 
involving the fimbriae. The small sample 
size and the low number of cases of 
STIC may not be statistically adequate 
to comment on how rare such a case 
might be in low-risk patients.  
In our study, one patient with atypical 
mucosa in the fimbriae was found to 
have a STIC in the non-fimbriated tube. 
Thus, any atypia in the fimbriae requires 
examination of all remaining tissue from 
the non-fimbriated portions of both 
fallopian tubes. When the dissection of 
the tube is carefully performed at slice 
intervals no thicker than 2 or 3 mm, 
there is no need to examine more than a 
single H&E stained slide per tissue 
block.  In addition, automatic deeper 
levels are not needed when these 
dissection conditions are practiced.17 
It is worth considering that a pathologic 
diagnosis of unknown clinical or genetic 
significance may provoke concern 
and/or anxiety in the clinician and/or 
patient since appropriate management 
remains to be defined. This is one of the 
potential negative effects of increasing 
surveillance for STIC in low-risk 
patients, since a subset of patients will 
be found to have STIC. The potential for 
overdiagnosis of STIC is similarly 
undesirable. The risks for overdiagnosis 
or underdiagnosis of atypical findings 
remain unknown. As pathologists are 
being guided to direct more attention to 
the fallopian tubes, familiarity with 
diagnostic criteria becomes paramount. 
Conclusions 
We propose that our results support 
changing the standard of care for 
sampling unremarkable fallopian tubes 
in all patients especially those who are 
at low risk for HBOC.  
Our protocol recommends microscopic 
examination of the entire fimbriae from 
all patients regardless of the clinical 
context. This represents a novel method 
for early detection of sporadic tubal 
carcinoma, a putative precursor to 
advanced-stage pelvic cancer. As there 
is an increase in opportunistic 
salpingectomy in women undergoing 
benign pelvic surgeries such as 
hysterectomy, examination of the tubal 
fimbria as mentioned previously may 
help in identifying the earliest stage of 
tubal carcinoma, especially in low risk 
patients.  
Further studies are also needed to 
detect the long term behavior of STIC 
and the behavior of various forms of 
atypical mucosal proliferations in low-
risk patients. 
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